Weinong Guo in

Weinong Guo

Login to view DISC.
Senior Vice President, Clinical Development at Alnylam Pharmaceuticals
📍 Warren, New Jersey, United States

Weinong Guo is the Senior Vice President of Clinical Development at Alnylam Pharmaceuticals, where he leads the advancement of RNAi programs for cardiometabolic diseases. His extensive career includes a 14-year tenure at Novartis, where he played a key role in developing major cardiovascular drugs. He holds an MD from Soochow University and a PhD from Nagoya University.

Originally from China, Weinong travels back whenever possible to visit his parents in Suzhou. He is personally motivated by their long-term struggle with hypertension, which has been difficult to control with traditional daily medications. This firsthand experience with the challenges of chronic disease management fuels his professional passion.

His work developing a twice-yearly injectable treatment for hypertension is directly inspired by his parents health struggles.

Read the full overview →
Experience
29 Years
Current Role
Senior Vice President, Clinical Development
Job Level
Leadership
Location
Warren, New Jersey, United States
Personality Overview

How Weinong shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Weinong cares about

RNAi Therapeutics
Leads clinical development for innovative RNAi medicines at Alnylam, aiming to transform treatment for prevalent diseases by silencing disease-causing genes before proteins are made.
Hypertension Treatment
He is a key figure in the development of zilebesiran, a novel RNAi therapeutic for hypertension, and is motivated by his own parents' struggles with the condition.
+5 more topics Login to view topics
Career

Work history

5-2021
Senior Vice President, Clinical Development
Alnylam Pharmaceuticals
6-2020 - 5-2021
Head of Development
HENGRUI USA LTD
2-2019 - 6-2020
Sr. Global Clinical Program Head, Cardiovascular, Renal and Metabolism Development Unit
Novartis
12-2013 - 1-2019
Sr. Global Program Clinical Head, CV Therapeutic Area, CardioMetabolic Development Unit
Novartis Pharmaceutical Corporation
4-2013 - 12-2013
Global Program Medical Director, Lipid/Metabolism Therapeutic Area, Critical Care Franchise
Novartis Pharmaceutical Corporation
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1993 - 1997
PhD
Nagoya University
1986 - 1991
MD
Soochow University (CN)
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Weinong. Free, 10 seconds.